A detailed history of Hancock Whitney Corp transactions in Dexcom Inc stock. As of the latest transaction made, Hancock Whitney Corp holds 6,312 shares of DXCM stock, worth $505,212. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,312
Previous 109,791 94.25%
Holding current value
$505,212
Previous $12.4 Million 96.6%
% of portfolio
0.01%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$64.0 - $116.06 $6.62 Million - $12 Million
-103,479 Reduced 94.25%
6,312 $423,000
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $86,593 - $110,253
785 Added 0.72%
109,791 $12.4 Million
Q1 2024

May 16, 2024

BUY
$114.22 - $140.1 $877,095 - $1.08 Million
7,679 Added 7.58%
109,006 $15.1 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $7.65 Million - $12.6 Million
101,327 New
101,327 $12.6 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.